The following stocks have recently had coverage initiated on them by stock analysts.<\/p>\n
Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\nAlere (ALR)<\/a><\/li>Univ Elec (UEIC)<\/a><\/li>Quidel (QDEL)<\/a><\/li>OraSure Tech (OSUR)<\/a><\/li>Molycorp (MCP)<\/a><\/li>Meridian Bioscience (VIVO)<\/a><\/li>Kimberly-Clark (KMB)<\/a><\/li>Gilead Sciences (GILD)<\/a><\/li>Genomic Health (GHDX)<\/a><\/li>Gen-Probe (GPRO)<\/a><\/li>China Cord Blood (CO)<\/a><\/li>Amgen (AMGN)<\/a><\/li>AspenBio Pharma (APPY)<\/a><\/li>Beckman Coulter (BEC)<\/a><\/li>Becton Dickinson (BDX)<\/a><\/li>Biogen Idec (BIIB)<\/a><\/li>Celgene (CELG)<\/a><\/li>Cepheid (CPHD)<\/a><\/li><\/ul><\/nav><\/div>\n<\/span>Alere (ALR)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Alere at Buy<\/p>\n<\/span>Univ Elec (UEIC)<\/a><\/span><\/h4>\n Dougherty & Company<\/b> has initiated coverage for Univ Elec at Buy<\/p>\n<\/span>Quidel (QDEL)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Quidel at Buy<\/p>\n<\/span>OraSure Tech (OSUR)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for OraSure Tech at Buy<\/p>\n<\/span>Molycorp (MCP)<\/a><\/span><\/h4>\n Dahlman Rose<\/b> has initiated coverage for Molycorp at Buy<\/p>\n<\/span>Meridian Bioscience (VIVO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Alere at Buy<\/p>\n<\/span>Univ Elec (UEIC)<\/a><\/span><\/h4>\n Dougherty & Company<\/b> has initiated coverage for Univ Elec at Buy<\/p>\n<\/span>Quidel (QDEL)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Quidel at Buy<\/p>\n<\/span>OraSure Tech (OSUR)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for OraSure Tech at Buy<\/p>\n<\/span>Molycorp (MCP)<\/a><\/span><\/h4>\n Dahlman Rose<\/b> has initiated coverage for Molycorp at Buy<\/p>\n<\/span>Meridian Bioscience (VIVO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Dougherty & Company<\/b> has initiated coverage for Univ Elec at Buy<\/p>\n<\/span>Quidel (QDEL)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Quidel at Buy<\/p>\n<\/span>OraSure Tech (OSUR)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for OraSure Tech at Buy<\/p>\n<\/span>Molycorp (MCP)<\/a><\/span><\/h4>\n Dahlman Rose<\/b> has initiated coverage for Molycorp at Buy<\/p>\n<\/span>Meridian Bioscience (VIVO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Quidel at Buy<\/p>\n<\/span>OraSure Tech (OSUR)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for OraSure Tech at Buy<\/p>\n<\/span>Molycorp (MCP)<\/a><\/span><\/h4>\n Dahlman Rose<\/b> has initiated coverage for Molycorp at Buy<\/p>\n<\/span>Meridian Bioscience (VIVO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for OraSure Tech at Buy<\/p>\n<\/span>Molycorp (MCP)<\/a><\/span><\/h4>\n Dahlman Rose<\/b> has initiated coverage for Molycorp at Buy<\/p>\n<\/span>Meridian Bioscience (VIVO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Dahlman Rose<\/b> has initiated coverage for Molycorp at Buy<\/p>\n<\/span>Meridian Bioscience (VIVO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Meridian Bioscience at Hold<\/p>\n<\/span>Kimberly-Clark (KMB)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Jefferies<\/b> has initiated coverage for Kimberly-Clark at Hold<\/p>\n<\/span>Gilead Sciences (GILD)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
UBS<\/b> has initiated coverage for Gilead Sciences at Buy<\/p>\n<\/span>Genomic Health (GHDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Genomic Health at Hold<\/p>\n<\/span>Gen-Probe (GPRO)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Gen-Probe at Buy<\/p>\n<\/span>China Cord Blood (CO)<\/a><\/span><\/h4>\n Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Jefferies<\/b> has initiated coverage for China Cord Blood at Buy<\/p>\n<\/span>Amgen (AMGN)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
UBS<\/b> has initiated coverage for Amgen at Neutral<\/p>\n<\/span>AspenBio Pharma (APPY)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for AspenBio Pharma at Hold<\/p>\n<\/span>Beckman Coulter (BEC)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Beckman Coulter at Hold<\/p>\n<\/span>Becton Dickinson (BDX)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Becton Dickinson at Hold<\/p>\n<\/span>Biogen Idec (BIIB)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
UBS<\/b> has initiated coverage for Biogen Idec at Neutral<\/p>\n<\/span>Celgene (CELG)<\/a><\/span><\/h4>\n UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
UBS<\/b> has initiated coverage for Celgene at Buy<\/p>\n<\/span>Cepheid (CPHD)<\/a><\/span><\/h4>\n Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n
Canaccord Genuity<\/b> has initiated coverage for Cepheid at Buy<\/p>\n« Return to Stock Market News<\/a> « <\/div>\n\n\n